Last reviewed · How we verify

NCT06983457

Comparative Effects of TherapeuticU and Shockwave Therapy on Pain and QOL in Patients With Chronic Heel Spur Pain

Active, enrolled NA Last updated 21 May 2025
What this trial tests

NA trial testing Therapeutic ultrasound in Heel Spur in 41 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
20 March 2025
Primary endpoint
20 June 2025
20 February 2026

Quick facts

Lead sponsorSuperior University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment41
Start date20 March 2025
Primary completion20 June 2025
Estimated completion20 February 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

Adults 30 to 60, any sex, with Heel Spur. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to compare the effectiveness of therapeutic ultrasound (TUS) and extracorporeal shockwave therapy (ESWT) in managing chronic heel spur pain and improving patients' quality of life. Chronic heel spur pain, often associated with plantar fasciitis, is a debilitating condition that affects mobility and daily activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Therapeutic ultrasound

Trials testing the same drug.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06983457.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing